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medial plateaus, iMT) of OA in Japanese.
Methods: Genome-wide DNA methylation analysis was performed
using Illumina Inﬁnium HumanMethylation450 BeadChip array on DNA
extracted from the cartilage of oLT, iLT and iMT region of 8 patients. Raw
IDAT ﬁles were analyzed using package “minﬁ” in R. Data was nor-
malized through SWAN (subquantile normalization) method. Multi-
dimensional scaling (MDS) was used to identify the outliers. Probes that
locate on X/Y chromosomes were removed before applying F test to ﬁnd
out the differential methylated sites of iLT vs oLT and iMT vs oLT. Mul-
tidimensional scaling of the methylation beta values revealed sig-
niﬁcantclusters related to cartilage. F test with p value less than 0.05
and jDbj greater than 0.15 were used to identify the differential
methylated sites. Genes with differentially methylated CpG sites were
analyzed to identify gene ontologies, pathways, and upstream
regulators.
Results: We identiﬁed 310 differentially methylated sites (DMS) cov-
ering 147 genes in comparison of iMT vs. oLT region. Of these, 122(39%)
DMS were hypermethylated and 188 (61%) were hypomethylated.
However, in the comparison of iLT vs. oLT region, we only found 22
differential methylated sites (12 hypermethylated and 10 hypomethy-
lated). The dramatic difference in DMS numbers of iLT and iMT suggests
that methylation is highly involved only at the very late stage of OA. The
DMS we found in iMT cartilage include genes reported related to OA, for
instance, BMP6, COL14A1, NFATC1, and SPOCK1. Enrichment analysis of
the genes with DMS revealed signiﬁcant enrichment of HOX family
genes and development pathways.
Conclusions: In the current study, we have identiﬁed the methylation
changes in both the iLT region and iMT region, which represent the
intermediat and late stage of OA disease. Our data suggested that the
signiﬁcant changes in methylation occurred at during the late stages of
OA. The development pathways and HOX family genes enriched at the
late stage of OA implicated new aspect of cartilage maintenance in
adulthood. The further study of the underlying mechanism may supply
a direction for future cartilage regeneration approaches.
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GENOME-WIDE DNA METHYLATION PROFILING OF OSTEOARTHRITIC
SUBCHONDRAL BONE
Y. Zhang y, N. Fukui z, M. Yahata y, M. Lee y. yRIKEN, Yokohama, Japan;
zUniv. of Tokyo, Tokyo, Japan
Purpose: Osteoarthritis (OA) is a disease of the whole joint organ
involving pathological changes of articular cartilage (AC) and structural
changes of underlying subchondral bone (SB). Several studies looking at
changes in methylation has been performed, but none of them were
performed on the subchondral bone. We previously reported a novel
method for isolating site-matched overlying AC and underlying SB from
regions of interest respectively from the human knee tibial plateau.
Thus, the aim of this study was to characterize the genome-wide DNA
methylation proﬁle from regions representing early (oLT), intermediate
(iLT) and late stage (iMT) of OA in the subchondral bone from knee
joints isolated from arthroplasty in the Japanese population.
Methods: Genome-wide DNA methylation proﬁling was performed
using the Illumina Inﬁnium HumanMethylation450 BeadChip array in
the DNA extracted from the subchondral bone of 8 patients. Raw IDAT
ﬁles were analyzed using the package “minﬁ” in R. Normalization of the
data was performed through the SWAN (subquantile normalization)
method. The outliers were identiﬁed using multidimensional scaling
(MDS). Probes on X/Y chromosomes were removed. F test was used to
determine the differential methylated sites between iLT vs oLT and iMT
vs oLT. Multidimensional scaling of the methylation beta values reveals
signiﬁcant clusters related to subchondral bone. F test with p smaller
than 0.05 and the cutoff threshold of jDbj greater than0.15 were used to
identify the differential methylated sites. Genes with differentially
methylated CpG sites were analyzed to identify gene ontologies, path-
ways, and upstream regulators.
Results: A total of 252 differentially methylated sites (DMS) covering
119 genes in comparison of iMT vs. oLT region. Of these, 114(45%) DMS
were hypermethylated and 138 (55%) were hypomethylated. However,
in the comparison of iLT vs. oLT region, we only found 35 differential
methylated sites (23 hypermethylated and 12 hypomethylated). The
dramatic difference in DMS numbers of iLT and iMT suggests that
methylation is highly involved at the late stage of OA. Enrichmentanalysis of the genes with DMS of iMT vs oLT revealed signiﬁcant
enrichment of HOX family genes, skeletal development and morpho-
genesis pathways, and transcription regulatory pathways, which is
similar to the result from cartilage, but the members of HOX family
genes differ, HOXC genes showed changed methylation status only in
subchondral bone but not cartilage. Genes with DMS of iLT vs oLT
showed enrichment of DNA binding and transcription regulation, but
not HOX or development.
Conclusions: To our best knowledge, this study represents the ﬁrst and
the most comprehensive direct assessment of methylation proﬁling
conducted in OA subchondral bone. With the ability to directly studying
genetic proﬁles of subchondral bone could further the understanding of
the pathogenesis of the disease.
307
TRANSTHYRETIN AND AMYLOID IN CARTILAGE AGING AND
OSTEOARTHRITIS
Y. Akasaki y, O. Alvarez-Garcia y, N. Reixach y, J.N. Buxbaum y,
Y. Iwamoto z, M.K. Lotz y. y The Scripps Res. Inst., La Jolla, CA, USA;
zKyushu Univ., Fukuoka, Japan
Purpose: Deposition of amyloid is a common aging-associated phe-
nomenon and a key factor in the pathogenesis of several aging-related
diseases. Osteoarthritis (OA) is the most prevalent joint disease and
aging is its major risk factor. Although amyloid deposits appear to be a
prevalent in OA-affected joints, their composition and effects on cell
and tissue function are unknown. Transthyretin (TTR) is an amyloido-
genic protein. Point mutations in the TTR gene cause of familial amy-
loidotic polyneuropathy and cardiomyopathy. Wild-type TTR can also
assemble into amyloid deposits and this may be facilitated by oxidation,
or the presence of sulfated glycosaminoglycans. This study addressed
TTR deposition in aging and OA-affected knee cartilage and effects of
TTR on chondrocyte function.
Methods: Amyloid deposition in normal and OA human knee cartilage
was determined by Congo-red staining and polarized light microscopy.
TTR in cartilage and synovial ﬂuid was analyzed by immunohis-
tochemistry and western blotting. TTR gene expression in chondrocytes
was studied by quantitative PCR and RNA sequencing. Effects of wild
type and mutant TTR were studied in normal human chondrocyte
cultures with measurements of cell viability and OA-related gene
expression.
Results: There was no amyloid deposition in young normal cartilage. In
contrast, 58% (7/12) of aged normal cartilage and 100% (12/12) of OA
cartilage samples had Congo red staining. TTR was detectable in all OA
and a majority of aged but not in young normal cartilage and pre-
dominantly located at the cartilage surfaces. TTR is not produced by
chondrocytes at substantial levels and synovial ﬂuid levels are similar in
normal and OA affected knees. In chondrocytes, TTR induces cell death,
the expression of proinﬂammatory cytokines and extracellular matrix
degrading enzymes. This was observed for the amyloidogenic but not
for the non-amyloidogenic TTR mutant. Effects of TTR on cell viability
and gene expression are mediated by activation of TLR4 signaling and
MAP kinases. TTR-induced cytotoxicity was inhibited by resveratrol, a
plant polyphenol and the salicylic acid derivate diﬂunisal which both
stabilize the native tetrameric structure of TTR. Studies using transgenic
mice that overexpress wild type human TTR showed that surgically
induced OA was more severe than in wild type mice. In addition, hTTR
transgenic mice also showed more severe spontaneous aging related
OA-like joint changes in cartilage and synovium.
Conclusions: These ﬁndings are the ﬁrst to suggest that TTR amyloid
deposition may not represent an inconsequential aging-related phe-
nomenon but contribute to cell and extracellular matrix damage in
articular cartilage.
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DEVELOPMENTAL SWITCH IN SOX9 EXPRESSION IN ARTICULAR
CARTILAGE IS REGULATED BY EPIGENETIC HISTONE METHYLATION
M. ZHANG, Q. Hua, A. Miller, N. Barnthouse, J. Wang. Univ. of Kansas
Med. Ctr., Kansas City, KS, USA
Purpose:While the role of the SOX9 transcription factor in chondrocyte
differentiation and cartilage formation during skeletal development is
well documented, age-dependent SOX9 expression in articular
